Rice Hall James & Associates, LLC Albireo Pharma, Inc. Transaction History

Rice Hall James & Associates, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$18.01 - $23.78 $169,059 - $223,222	9,387 Added 1.86%	513,525 $0
Q3 2022 Nov 01, 2022	BUY	$16.32 - $26.37 $625,610 - $1.01 Million	38,334 Added 8.23%	504,138 $9.76 Million
Q2 2022 Aug 08, 2022	SELL	$18.54 - $37.29 $170,326 - $342,583	-9,187 Reduced 1.93%	465,804 $9.25 Million
Q1 2022 May 05, 2022	BUY	$23.94 - $33.74 $406,501 - $572,905	16,980 Added 3.71%	474,991 $14.2 Million
Q4 2021 Feb 14, 2022	SELL	$21.19 - $31.29 $1.05 Million - $1.55 Million	-49,670 Reduced 9.78%	458,011 $10.7 Million

Q3 2021 Nov 09, 2021	SELL	$27.36 - $35.98 $76,224 - $100,240	-2,786 Reduced 0.55%	507,681 $15.8 Million
Q2 2021 Jul 29, 2021	SELL	$28.9 - $36.87 $1.8 Million - $2.3 Million	-62,432 Reduced 10.9%	510,467 $18 Million
Q1 2021 May 14, 2021	BUY	$32.03 - $42.85 $10.1 Million - $13.5 Million	315,527 Added 122.6%	572,899 $20.2 Million
Q4 2020 Feb 16, 2021	BUY	$31.56 - $42.16 $5.37 Million - $7.17 Million	170,014 Added 194.62%	257,372 $9.65 Million
Q3 2020 Nov 16, 2020	BUY	$23.19 - $41.61 $2.03 Million - $3.63 Million	87,358 New	87,358 $2.92 Million

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.